Cell transplantation for Parkinson's disease: present status
- PMID: 15206816
- PMCID: PMC11529974
- DOI: 10.1023/b:cemn.0000022764.94760.3f
Cell transplantation for Parkinson's disease: present status
Abstract
1. Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of neurons in the substantia nigra pars compacta and a striatal deficiency of dopamine. PD typically affects people in late middle age and progresses slowly. In the early stages of the disease, treatment targeting the dopaminergic network is effective. However, with disease progression, transplantation is an option for repairing and replacing missing dopaminergic neurons. 2. In this review, we evaluate the tissue grafts and cellular therapies that have and are being considered. Clinical trials were originally derived from transplants of adrenal medullary chromaffin cells and embryonic nigral dopaminergic neurons in patients with PD. 3. Recently, novel molecular and cellular treatments are being utilized in animals and these include embryonic stem cells, fetal cells from pigs, or transfected cells. In spite of new molecular techniques and some 20 years of experience, the transplantation therapy for PD has today the same problems and results as the first reports which used neural fetal tissue or adrenal grafts.
Similar articles
-
Stem cell transplantation: a promising therapy for Parkinson's disease.J Neuroimmune Pharmacol. 2007 Sep;2(3):243-50. doi: 10.1007/s11481-007-9074-2. Epub 2007 May 9. J Neuroimmune Pharmacol. 2007. PMID: 18040857 Review.
-
Rewiring the brain with cell transplantation in Parkinson's disease.Trends Neurosci. 2011 Mar;34(3):124-33. doi: 10.1016/j.tins.2011.01.003. Trends Neurosci. 2011. PMID: 21316770 Review.
-
Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.Prog Brain Res. 2002;138:411-20. doi: 10.1016/S0079-6123(02)38090-7. Prog Brain Res. 2002. PMID: 12432781 Review. No abstract available.
-
Neural transplantation for Parkinson's disease.Cell Mol Neurobiol. 1999 Feb;19(1):67-78. doi: 10.1023/a:1006964507916. Cell Mol Neurobiol. 1999. PMID: 10079966 Free PMC article. Review.
-
Stem cell treatment for Parkinson's disease: an update for 2005.Curr Opin Neurol. 2005 Aug;18(4):376-85. doi: 10.1097/01.wco.0000174298.27765.91. Curr Opin Neurol. 2005. PMID: 16003112 Review.
Cited by
-
Isolation, characterization, and differentiation of progenitor cells from human adult adrenal medulla.Stem Cells Transl Med. 2012 Nov;1(11):783-91. doi: 10.5966/sctm.2012-0022. Epub 2012 Oct 29. Stem Cells Transl Med. 2012. PMID: 23197690 Free PMC article.
-
Generation of Adrenal Chromaffin-like Cells from Human Pluripotent Stem Cells.Stem Cell Reports. 2018 Jan 9;10(1):134-150. doi: 10.1016/j.stemcr.2017.11.003. Epub 2017 Dec 7. Stem Cell Reports. 2018. PMID: 29233551 Free PMC article.
-
Chromaffin progenitor cells from the adrenal medulla.Cell Mol Neurobiol. 2010 Nov;30(8):1417-23. doi: 10.1007/s10571-010-9571-3. Epub 2010 Nov 16. Cell Mol Neurobiol. 2010. PMID: 21080061 Free PMC article.
-
Preconditioning as a potential strategy for the prevention of Parkinson's disease.Mol Neurobiol. 2015 Feb;51(1):313-30. doi: 10.1007/s12035-014-8689-6. Epub 2014 Apr 3. Mol Neurobiol. 2015. PMID: 24696268 Review.
-
The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.Int J Mol Sci. 2010 Aug 5;11(8):2875-900. doi: 10.3390/ijms11082875. Int J Mol Sci. 2010. PMID: 21152280 Free PMC article. Review.
References
-
- Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. TINS12(10):366-374. - PubMed
-
- Allen, G. S., Burns R. S., and Tullipan, M. B. (1989). Adrenal medulary transplantation to the caudate nucleus in Parkinson's disease. Initial clinical results in 18 patients. Arch. Neurol.46:487-491. - PubMed
-
- Backlund, E.-O., Granberg, P.-O., Hamberger, B., Knutson, E., Martensson, A., Sedvall, G., Seiger, A., and Olson, L. (1985). Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J. Neurosurg.62:169-173. - PubMed
-
- Barker, R. A. (2002). Repairing the brain in Parkinson's disease: Where next? Mov. Disord.17(2):233-241. - PubMed
-
- Björklund, L. M., Sánchez-Pernaute, R., Chung, S., Andersson, T., Ching-Chen, I. Y., McNaught, K. P., Brownell, A. L., Jenkins, B. G., Wahlestedt, C., Kim, K. S., and Isacson, O. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. PNAS99(4):2344-2349. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous